Global Glioma Diagnosis and Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3431

A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas.
Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.
In 2018, the global Glioma Diagnosis and Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Glioma Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioma Diagnosis and Treatment development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Emcure Pharmaceuticals
Sigma-Aldrich
Pfizer
Taj Pharmaceuticals
Novartis International
Teva Pharmaceutical
GE Healthcare
Siemens Healthcare
Philips Healthcare
Shimadzu Corporation
Toshiba Medical
Merck
Roche
Arbor Pharmaceuticals
Sun Pharmaceutical

Market segment by Type, the product can be split into
Diagnosis (CT, MRI)
Treatment (Surgery, Chemotherapy)

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glioma Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players.
To present the Glioma Diagnosis and Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glioma Diagnosis and Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glioma Diagnosis and Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Diagnosis (CT, MRI)
1.4.3 Treatment (Surgery, Chemotherapy)
1.5 Market by Application
1.5.1 Global Glioma Diagnosis and Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Glioma Diagnosis and Treatment Market Size
2.2 Glioma Diagnosis and Treatment Growth Trends by Regions
2.2.1 Glioma Diagnosis and Treatment Market Size by Regions (2014-2025)
2.2.2 Glioma Diagnosis and Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Glioma Diagnosis and Treatment Market Size by Manufacturers
3.1.1 Global Glioma Diagnosis and Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Glioma Diagnosis and Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glioma Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Glioma Diagnosis and Treatment Key Players Head office and Area Served
3.3 Key Players Glioma Diagnosis and Treatment Product/Solution/Service
3.4 Date of Enter into Glioma Diagnosis and Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Glioma Diagnosis and Treatment Market Size by Type (2014-2019)
4.2 Global Glioma Diagnosis and Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Glioma Diagnosis and Treatment Market Size (2014-2019)
5.2 Glioma Diagnosis and Treatment Key Players in United States
5.3 United States Glioma Diagnosis and Treatment Market Size by Type
5.4 United States Glioma Diagnosis and Treatment Market Size by Application

6 Europe
6.1 Europe Glioma Diagnosis and Treatment Market Size (2014-2019)
6.2 Glioma Diagnosis and Treatment Key Players in Europe
6.3 Europe Glioma Diagnosis and Treatment Market Size by Type
6.4 Europe Glioma Diagnosis and Treatment Market Size by Application

7 China
7.1 China Glioma Diagnosis and Treatment Market Size (2014-2019)
7.2 Glioma Diagnosis and Treatment Key Players in China
7.3 China Glioma Diagnosis and Treatment Market Size by Type
7.4 China Glioma Diagnosis and Treatment Market Size by Application

8 Japan
8.1 Japan Glioma Diagnosis and Treatment Market Size (2014-2019)
8.2 Glioma Diagnosis and Treatment Key Players in Japan
8.3 Japan Glioma Diagnosis and Treatment Market Size by Type
8.4 Japan Glioma Diagnosis and Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Glioma Diagnosis and Treatment Market Size (2014-2019)
9.2 Glioma Diagnosis and Treatment Key Players in Southeast Asia
9.3 Southeast Asia Glioma Diagnosis and Treatment Market Size by Type
9.4 Southeast Asia Glioma Diagnosis and Treatment Market Size by Application

10 India
10.1 India Glioma Diagnosis and Treatment Market Size (2014-2019)
10.2 Glioma Diagnosis and Treatment Key Players in India
10.3 India Glioma Diagnosis and Treatment Market Size by Type
10.4 India Glioma Diagnosis and Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Glioma Diagnosis and Treatment Market Size (2014-2019)
11.2 Glioma Diagnosis and Treatment Key Players in Central & South America
11.3 Central & South America Glioma Diagnosis and Treatment Market Size by Type
11.4 Central & South America Glioma Diagnosis and Treatment Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glioma Diagnosis and Treatment Introduction
12.1.4 Thermo Fisher Scientific Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Emcure Pharmaceuticals
12.2.1 Emcure Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glioma Diagnosis and Treatment Introduction
12.2.4 Emcure Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.2.5 Emcure Pharmaceuticals Recent Development
12.3 Sigma-Aldrich
12.3.1 Sigma-Aldrich Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glioma Diagnosis and Treatment Introduction
12.3.4 Sigma-Aldrich Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.3.5 Sigma-Aldrich Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glioma Diagnosis and Treatment Introduction
12.4.4 Pfizer Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Taj Pharmaceuticals
12.5.1 Taj Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glioma Diagnosis and Treatment Introduction
12.5.4 Taj Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.5.5 Taj Pharmaceuticals Recent Development
12.6 Novartis International
12.6.1 Novartis International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Glioma Diagnosis and Treatment Introduction
12.6.4 Novartis International Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.6.5 Novartis International Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Glioma Diagnosis and Treatment Introduction
12.7.4 Teva Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Company Details
12.8.2 Company Description and Business Overview
12.8.3 Glioma Diagnosis and Treatment Introduction
12.8.4 GE Healthcare Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.8.5 GE Healthcare Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Details
12.9.2 Company Description and Business Overview
12.9.3 Glioma Diagnosis and Treatment Introduction
12.9.4 Siemens Healthcare Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.9.5 Siemens Healthcare Recent Development
12.10 Philips Healthcare
12.10.1 Philips Healthcare Company Details
12.10.2 Company Description and Business Overview
12.10.3 Glioma Diagnosis and Treatment Introduction
12.10.4 Philips Healthcare Revenue in Glioma Diagnosis and Treatment Business (2014-2019)
12.10.5 Philips Healthcare Recent Development
12.11 Shimadzu Corporation
12.12 Toshiba Medical
12.13 Merck
12.14 Roche
12.15 Arbor Pharmaceuticals
12.16 Sun Pharmaceutical

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details